{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:57:21Z","timestamp":1781672241636,"version":"3.54.5"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012175","name":"Zhejiang Traditional Chinese Medicine Administration","doi-asserted-by":"publisher","award":["2026ZL0252"],"award-info":[{"award-number":["2026ZL0252"]}],"id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012175","name":"Zhejiang Traditional Chinese Medicine Administration","doi-asserted-by":"publisher","award":["2026ZL0695"],"award-info":[{"award-number":["2026ZL0695"]}],"id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Piperacillin-tazobactam (PIP-TAZ) is characterized by its broad antimicrobial spectrum, strong antibacterial activity, and low toxicity, playing a vital role in the treatment of infectious diseases. However, with its widespread use, reports of drug-induced immune hemolytic anemia (DIIHA) and drug-induced thrombocytopenia (DITP) have begun to emerge. Due to the relatively rare clinical incidence of these conditions, clinicians often have an inadequate understanding and lack corresponding management experience. Fortunately, we encountered a case in clinical practice that we quickly identified and successfully treated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>An 83-year-old Chinese female patient was treated with PIP-TAZ for pneumonia. On the fourth day of treatment, she exhibited pronounced symptoms of jaundice, accompanied by elevated total bilirubin levels, severe hemolytic anemia and thrombocytopenia. Upon investigating the underlying cause, we found that the concentration of PIP-TAZ in her blood was significantly higher than the normal therapeutic range, and PIP-TAZ-dependent antibodies were detected in her serum. We ultimately diagnosed her with DIIHA combined with DITP. Following prompt recognition and management, the patient made a full recovery and was subsequently discharged.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This article presents a case of acute immune hemolytic anemia and immune thrombocytopenia induced by PIP-TAZ. Effective treatment strategies include the prompt identification and discontinuation of the offending drug, blood transfusions, intravenous immunoglobulin (IVIG), corticosteroid therapy, and careful monitoring of vital signs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1844022","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:44:05Z","timestamp":1781671445000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: rapid exacerbation of autoimmune hemolysis and severe immune - mediated thrombocytopenia induced by piperacillin \u2013 tazobactam"],"prefix":"10.3389","volume":"13","author":[{"given":"Juan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Nephrology, Hangzhou Linping Hospital of Traditional Chinese Medicine, Hangzhou","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongliang","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Tongde Hospital of Zhejiang Province, Hangzhou","place":["Zhejiang, China"]},{"name":"Zhejiang Academy of Traditional Chinese Medicine, Hangzhou","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Tongde Hospital of Zhejiang Province, Hangzhou","place":["Zhejiang, China"]},{"name":"Zhejiang Academy of Traditional Chinese Medicine, Hangzhou","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfang","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Tongde Hospital of Zhejiang Province, Hangzhou","place":["Zhejiang, China"]},{"name":"Zhejiang Academy of Traditional Chinese Medicine, Hangzhou","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s11096-020-01071-8","article-title":"Hematologic adverse effects induced by piperacillin-tazobactam: a systematic review of case reports.","volume":"42","author":"Wang","year":"2020","journal-title":"Int J Clin Pharm."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1111\/trf.15591","article-title":"Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study.","volume":"59","author":"Roehmel","year":"2019","journal-title":"Transfusion."},{"key":"B3","doi-asserted-by":"publisher","first-page":"bcr2012007801","DOI":"10.1136\/bcr-2012-007801","article-title":"Life-threatening piperacillin-induced immune haemolysis in a patient with cystic fibrosis.","volume":"2013","author":"Marik","year":"2013","journal-title":"BMJ Case Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1423-0410.2002.00188.x","article-title":"Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the \u2018immune complex\u2019 method.","volume":"83","author":"Arndt","year":"2002","journal-title":"Vox Sang."},{"key":"B5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/bjh.14654","article-title":"Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia.","volume":"177","author":"Hill","year":"2017","journal-title":"Br J Haematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11239-019-01848-3","article-title":"Cefepime challenge after piperacillin\/tazobactam-induced thrombocytopenia.","volume":"48","author":"Beaulieu","year":"2019","journal-title":"J Thromb Thrombolysis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1775491","DOI":"10.3389\/fmed.2026.1775491","article-title":"Piperacillin-tazobactam-associated thrombocytopenia with negative antiplatelet antibody testing: a case report and literature review.","volume":"13","author":"Tian","year":"2026","journal-title":"Front Med (Lausanne)."},{"key":"B8","doi-asserted-by":"publisher","first-page":"bcr2013201554","DOI":"10.1136\/bcr-2013-201554","article-title":"The CARE guidelines: consensus-based clinical case reporting guideline development.","volume":"2013","author":"Gagnier","year":"2013","journal-title":"BMJ Case Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/vox.13641","article-title":"The influence of HLA allele and haplotype on RhE alloimmunization among pregnant females in the Chinese Han population.","volume":"119","author":"Kong","year":"2024","journal-title":"Vox Sang."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.immuni.2024.06.009","article-title":"Antibody modulation of B cell responses-incorporating positive and negative feedback.","volume":"57","author":"Cyster","year":"2024","journal-title":"Immunity."},{"key":"B11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1309\/ajcpbvljzh6w6rqm","article-title":"Pathology consultation on drug-induced hemolytic anemia.","volume":"136","author":"Pierce","year":"2011","journal-title":"Am J Clin Pathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.21307\/immunohematology-2019-098","article-title":"Drug-induced immune hemolytic anemia: the last 30 years of changes.","volume":"30","author":"Arndt","year":"2014","journal-title":"Immunohematology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1365-2141.1985.tb04069.x","article-title":"Drug induced red blood cell autoantibodies co-developed with drug specific antibodies causing haemolytic anaemias.","volume":"61","author":"Habibi","year":"1985","journal-title":"Br J Haematol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.blre.2010.06.004","article-title":"Immune hemolytic anemia associated with drug therapy.","volume":"24","author":"Garratty","year":"2010","journal-title":"Blood Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1046\/j.1365-2141.1998.00615.x","article-title":"Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells.","volume":"100","author":"Garratty","year":"1998","journal-title":"Br J Haematol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1537-2995.2008.02028.x","article-title":"Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and\/or drug-induced nonimmunologic protein adsorption.","volume":"49","author":"Arndt","year":"2009","journal-title":"Transfusion."},{"key":"B17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.21307\/immunohematology-2019-102","article-title":"How we investigate drug-induced immune hemolytic anemia.","volume":"30","author":"Leger","year":"2014","journal-title":"Immunohematology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/j.1537-2995.2009.02544.x","article-title":"Piperacillin-induced immune hemolysis: new cases and a concise review of the literature.","volume":"50","author":"Mayer","year":"2010","journal-title":"Transfusion."},{"key":"B19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s15010-009-9227-8","article-title":"Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g\/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis.","volume":"38","author":"Kunzmann","year":"2010","journal-title":"Infection."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1373\/clinchem.2011.167213","article-title":"Sudden onset of severe anemia in a patient with cystic fibrosis.","volume":"58","author":"Nagao","year":"2012","journal-title":"Clin Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41572-024-00566-2","article-title":"Autoimmune haemolytic anaemias.","volume":"10","author":"Michel","year":"2024","journal-title":"Nat Rev Dis Primers."},{"key":"B22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.revmed.2014.05.009","article-title":"[Drug-induced immune hemolytic anemia: a retrospective study of 10 cases].","volume":"35","author":"Bollotte","year":"2014","journal-title":"Rev Med Interne."},{"key":"B23","doi-asserted-by":"publisher","first-page":"574540","DOI":"10.3389\/fimmu.2020.574540","article-title":"Rapidly exacerbating autoimmune hemolytic anemia together with marked cytokine storm triggered by pneumonia infection: a case report.","volume":"11","author":"Iwamoto","year":"2020","journal-title":"Front Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e26970","DOI":"10.7759\/cureus.26970","article-title":"Piperacillin-tazobactam induced rapid severe thrombocytopenia without known exposure.","volume":"14","author":"Bhaskarla","year":"2022","journal-title":"Cureus."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.2165\/00002018-200427150-00007","article-title":"Drug-induced immune thrombocytopenia.","volume":"27","author":"van den Bemt","year":"2004","journal-title":"Drug Saf."},{"key":"B26","doi-asserted-by":"publisher","first-page":"S827","DOI":"10.4103\/0975-7406.163595","article-title":"Drug-induced thrombocytopenic purpura.","volume":"7","author":"Sathiasekar","year":"2015","journal-title":"J Pharm Bioallied Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1182\/blood-2019-130966","article-title":"Serologic characterization of antibodies in patients experiencing piperacillin-induced immune thrombocytopenia.","volume":"134","author":"Rasmussen","year":"2019","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1505366","DOI":"10.3389\/fphar.2024.1505366","article-title":"Ceftriaxone-induced hemolytic anemia managed successfully in a 54-year-old woman: a case report and literature review.","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1478545","DOI":"10.3389\/fimmu.2024.1478545","article-title":"A case report of severe drug-induced immune hemolytic anemia caused by piperacillin.","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e94174","DOI":"10.7759\/cureus.94174","article-title":"A case of piperacillin-induced immune thrombocytopenia: diagnostic challenges and management.","volume":"17","author":"Patel","year":"2025","journal-title":"Cureus."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e59646","DOI":"10.7759\/cureus.59646","article-title":"Ceftriaxone-induced hemolytic anemia: a rare and fatal reaction.","volume":"16","author":"Dicaro","year":"2024","journal-title":"Cureus."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1111\/bjh.19817","article-title":"When is the use of intravenous immunoglobulin appropriate in immune thrombocytopenia?","volume":"205","author":"Dubois","year":"2024","journal-title":"Br J Haematol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e232944","DOI":"10.1136\/bcr-2019-232944","article-title":"Piperacillin-tazobactam induced bicytopenia in low cumulative treatment doses.","volume":"12","author":"Chen","year":"2019","journal-title":"BMJ Case Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.12968\/jowc.2021.0074","article-title":"Piperacillin\/tazobactam-induced sudden severe thrombocytopenia in a patient with a pressure ulcer: a case report.","volume":"33","author":"Roh","year":"2024","journal-title":"J Wound Care."},{"key":"B35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3324\/haematol.2020.250522","article-title":"Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study.","volume":"106","author":"Fattizzo","year":"2021","journal-title":"Haematologica."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1844022\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:44:28Z","timestamp":1781671468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1844022\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":35,"alternative-id":["10.3389\/fmed.2026.1844022"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1844022","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"article-number":"1844022"}}